Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Gonorrhea Vaccines: the Way Forward".

Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Gonorrhea Vaccines: the Way Forward". Clin Vaccine Immunol. 2016 Jun 22; Authors: Wetzler LM, Feavers IM, Gray-Owen SD, Jerse AE, Rice PA, Deal CD Abstract There is an urgent need for the development of an anti-gonococcal vaccine due to the increasing drug resistance found in this pathogen. The U.S. Center for Disease Control (CDC) has identified multidrug-resistant gonococci (GC) as one of 3 "urgent" hazard level threats to the U.S. POPULATION: In light of this, on June 29-30, 2015, the National Institute for Allergy and Infectious Diseases (NIAID) sponsored a workshop entitled "Gonorrhea Vaccines: the Way Forward". The goals of the workshop were to gather leaders in the field to discuss several key questions on the current status of gonorrhea vaccine research and the path forward to a licensed gonorrhea vaccine. Representatives from academia, industry, U.S Government agencies, and a state health department were in attendance. This review summarizes each of the 4 scientific sessions and a series of 4 breakout sessions that occurred during the one and a half days of the workshop. Topics raised as high priority for future development include: (i) a reinvigoration of basic research to understand gonococcal infection and immunity to allow intervention in processes essential for infection, (ii) clinical infection studies...
Source: Clinical and Vaccine Immunology - Category: Allergy & Immunology Authors: Tags: Clin Vaccine Immunol Source Type: research